MyChart
Updated December 6, 2022
Welia Health offers the following medication therapies for individuals who have tested positive for COVID-19. The use of these medications is prioritized based on those who are most at risk of severe COVID-19 complications.
Paxlovid
Type of medication
Antiviral
Authorized use(s)
Treatment of mild to moderate symptoms in high-risk patients with COVID-19 symptoms.
Age eligibility
Ages 12 years and older
Weight eligibility
88 pounds or more
Other criteria for treatment
- Test positive for SARS-CoV-2
- Be within 5 days of the start of symptoms
- Not pregnant or breastfeeding*
- Patient must not be hospitalized
Emergency Use Authorization (EUA)
The Food and Drug Administration has issued Emergency Use Authorizations for this medication. It may not be appropriate for all individuals. Learn more by downloading and reviewing fact sheets using the links provided.
Molnupiravir
Type of medication
Antiviral
Authorized use(s)
Treatment of mild to moderate symptoms in high-risk patients with COVID-19 symptoms.
Age eligibility
Ages 18 years and older
Weight eligibility
88 pounds or more
Other criteria for treatment
- Test positive for SARS-CoV-2
- Be within 5 days of the start of symptoms
- Not pregnant or breastfeeding
- Patient must not be hospitalized
Emergency Use Authorization (EUA)
The Food and Drug Administration has issued Emergency Use Authorizations for this medication. It may not be appropriate for all individuals. Learn more by downloading and reviewing fact sheets using the links provided.
If you are interested in any of these treatments, please call the clinic at 320.679.1313 and select option 2.
*Pregnant women will require an informed consent visit with a physician or advanced practice provider.
Resources for additional information
- Minnesota Helpline
1.833.431.2053 - Centers for Disease Control and Prevention Hotline
800-CDC-INFO (1.800.232.4635)
Sources:
Adapted with information from the Minnesota Department of Health: